# Effect of Sitagliptin on Graft Function Following Islet Transplantation

> **NCT00853944** · PHASE3 · TERMINATED · sponsor: **University of British Columbia** · enrollment: 12 (estimated)

## Conditions studied

- Islet Transplantation

## Interventions

- **DRUG:** sitagliptin

## Key facts

- **NCT ID:** NCT00853944
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2013-11-01
- **Final completion:** 2013-11-01
- **Target enrollment:** 12 (ESTIMATED)
- **Why stopped:** Sponsor withdrew funding du to lack of enrollment. Lack of enrollment was due to decrease in number of islet transplant procedures
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853944, "Effect of Sitagliptin on Graft Function Following Islet Transplantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00853944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*